Cointime

Fore Biotherapeutics

company

About

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

  • 1 - 10

Highlights

Total Funding Amount
$16M
Funding Rounds
2
Investors
2
Investments
32
Lead Investments
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$6M
Industries
Biotechnology,Health Care,Health Diagnostics,Life Science,Medical,Personal Health
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$16M
Fore Biotherapeutics has raised a total of $16M in funding over 2 rounds. Their latest funding was raised on Apr 30, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 30, 2018 Series Unknown $6M 1 SICAR — Detail
Dec 23, 2015 Series Unknown $10M 1 InterCure — Detail

Investments

Number of Investments
Number of Lead Investments
32
2
Fore Biotherapeutics has made 32 investments. Their most recent investment was on Oct 28, 2021, when nft42 raised $3.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 28, 2021 nft42
Seed $3.50M Art —
Aug 10, 2021 Saturn Technologies
Series Unknown $44M Apps —
Mar 30, 2021 SuperRare
Series A $9M Bitcoin —
Jan 1, 2021 NCX
Seed $4.40M Biometrics —
Dec 3, 2020 NCX
Seed $4.39M Biometrics —
Show More

Investors

Number of Lead Investors
Number of Investors
2
2
Fore Biotherapeutics is funded by 2 investors. SICAR and InterCure are the most recent investors.
Investor Name Lead Investor Funding Round
SICAR Yes Series Unknown
InterCure Yes Series Unknown
Cointime
Content
Company